Search Results 51-60 of 23209 for Androgen insensitivity syndrome

  1. Estrogen/Androgen Combination (Oral Route, Parenteral Route) Proper Use - Mayo Clinic

    For testosterone cypionate and estradiol cypionate. For injection dosage form: For treatment of certain signs of menopause, such as hot flashes and unusual ...

  2. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - Symptoms and causes - Mayo Clinic

    This complicated disorder may be triggered by an infection. While there's no cure for chronic fatigue syndrome, treatment focuses on easing symptoms.

  3. Tay-Sachs disease - Symptoms and causes - Mayo Clinic

    Tay-Sachs disease is a rare genetic disorder passed from parents to child. It's caused by the absence of an enzyme that helps break down fatty substances.

  4. Congenital myasthenic syndromes - Symptoms and causes - Mayo Clinic

    These rare hereditary conditions result in a problem in nerve stimulation, causing muscle weakness that worsens with physical activity.

  5. Testosterone therapy in women: Does it boost sex drive? - Mayo Clinic

    Answer From Yvonne Butler Tobah, M.D.. The hormone testosterone may boost sex drive for some women after menopause. But there's little research on how safe it ...

  6. Androgen (Oral Route, Parenteral Route, Subcutaneous Route, Topical Application Route, Transdermal Route) Precautions - Mayo Clinic

    For patients with diabetes mellitus (sugar diabetes):. This medicine may affect blood sugar levels. If you notice a change in the results of your blood or ...

  7. Hypereosinophilic syndrome - Symptoms and causes - Mayo Clinic

    Hypereosinophilic syndrome is a disorder of certain types of white blood cells that can cause life-threatening damage to your organs.

  8. Cushing syndrome - Symptoms and causes - Mayo Clinic

    High levels of the hormone cortisol in your body cause this endocrine disorder. Learn about symptoms, causes and treatment.

  9. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

    participants with known Gilbert's Syndrome ≤ 3 x ULN is permitted - ALT or AST ≤ 3.0 x ULN OR ≤ 5.0 x ULN for participants with liver metastases - Renal ...

  10. Mayo Clinic Identifies a Key Cellular Pathway in Prostate Cancer

    ... resistance to standard antiandrogen therapy,” says Haojie Huang, Ph.D., Mayo Clinic biochemist and senior author of the paper. SPOP mutations have been ...